Login to Your Account

Clinic Roundup

Friday, May 17, 2013
• Northwest Biotherapeutics Inc., of Bethesda, Md., said its Phase III trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription